I’m really interested in discussing the latest advancements in cardiovascular devices, particularly focusing on clinical efficacy and post-market performance. With recent studies showing varied results in outcomes, how are we ensuring the devices in use meet high standards long after their approval? It would be great to hear what others in the field think about ongoing surveillance and data collection practices.
It’s crucial that we continuously evaluate these devices after they’ve hit the market. Just like a good wine, they often improve with age, but a little corking can happen too! What do you think about implementing more real-world data collection for ongoing assessments?
, this drives me nuts too. While ongoing surveillance is essential, I’ve seen that post-market studies often fail to capture long-term data effectively. Getting reliable feedback from real-world use is key; maybe we should advocate for more structured feedback loops from clinicians using these devices. How do we gather that data in a way that’s manageable?